Natco Pharma Limited
Natco Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: NATCOPHARM and BSE: 524816 (ISIN INE987B01026).
It has a market capitalisation of ₹14,335 crore, a last close of ₹800.85 on 2026-10-19, a one-year return of -3.1%.
Valuation: a price-to-earnings ratio of 12.53x, a price-to-book ratio of 1.55x, a dividend yield of 0.6%.
Profitability: return on equity of 16.9%, return on capital employed of 17.9%, an operating margin of 30.2%.
Growth: sales growth of 14.6% a year over three years, net profit growth of 25.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.08x, promoter holding of 49.4%.
| Metric | Value |
|---|---|
| Market capitalisation | 14,335 |
| Last close | ₹800.85 |
| P/E (TTM) | 12.53x |
| P/B | 1.55x |
| Dividend yield | 0.6% |
| ROE (FY) | 16.9% |
| ROCE (FY) | 17.9% |
| Operating margin (TTM) | 30.2% |
| Sales growth, 3-year CAGR | 14.6% |
| Profit growth, 3-year CAGR | 25.6% |
| Debt / equity | 0.08x |
| Promoter holding | 49.4% |
| 1-year return | -3.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means